ebook Munafa Stock Market Course + Intraday & FNO calls  

       

BMY announcements Bristol-myers Squibb Company announcements and dividends declared NYSE

Bristol-myers Squibb Company Complete list of announcements declared & dividend announcements by Bristol-myers Squibb Company BMY

Bristol-myers Squibb Company BMY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Bristol-myers Squibb Company BMY

Bristol Myers Squibb To Repurchase Additional Bln Of Shares
(RTTNews) - Bristol-Myers Squibb Co. (BMY), a pharmaceutical company, said that its Board has authorized the repurchase of an additional billion of shares.
Announcement as on 07 December 2023

: Bristol Myers Squibb raises dividend by 5.3%
Bristol Myers Squibb Co. BMY said late Wednesday that its board has declared a quarterly dividend of 60 cents a share, a 5.3% increase over last year’s dividend of 57 cents a share. The dividend is payable on Feb. 1 to stockholders of record at the close
Announcement as on 06 December 2023

: Avidity’s stock soars on news of expanded collaboration with Bristol Myers that includes potential to receive up to .2 billion in milestone payments
Avidity Biosciences Inc. RNA said Tuesday it’s expanding its cardiovascular collaboration with Bristol Myers Squibb Co. BMY in a deal that will see Avidity receive 0 million upfront with the potential to earn up to .2 billion in milestone payments.
Announcement as on 28 November 2023

Is Bristol Myers Squibb Stock Undervalued At ?
Bristol Myers Squibb (NYSE: BMY) reported its Q3 results last month, with revenues meeting and earnings beating the street estimates, and we believe that BMY stock is undervalued, as discussed below. The company reported revenue of .0 billion and a
Announcement as on 13 November 2023

Bristol Myers Squibb Reports Positive Results From Phase 3 CheckMate-67T Trial
(RTTNews) - Halozyme Therapeutics, Inc. (HALO) Thursday said Bristol Myers Squibb (BMS) reported positive topline results from the Phase 3 CheckMate-67T trial evaluating subcutaneous Opdivo (nivolumab) with Halozyme's ENHANZE drug delivery technology for
Announcement as on 19 October 2023

Announcements by Bristol-myers Squibb Company first page | Next page | Prev page |

BMY Bristol-myers Squibb Company current price & indicator signals

Moving Averages for Bristol-myers Squibb Company

  • 5Day Average: 59.25
  • 12Day Average: 58.21
  • 20Day Average: 57.35
  • 50Day Average: 56.96
  • 100Day Average: 58.14
  • 150Day Average: 57.51
  • 200Day Average: 54.76

BMY Indicators & signals

Indicator MACD (12,26,9)

58.49, 57.69, 0.42
Indicator MACD is in positive zone

Indicator ADX (14)

36.11, 29.7, 13.94
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of BMY Bristol-myers Squibb Company are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
17 Fri Jul 2026 60.74 60.41 to 62.29 0.38% 1.23 times
16 Thu Jul 2026 60.51 58.50 to 60.56 3.08% 0.89 times
15 Wed Jul 2026 58.70 56.95 to 59.19 3.02% 0.89 times
14 Tue Jul 2026 56.98 56.78 to 59.46 -3.98% 1.19 times
13 Mon Jul 2026 59.34 57.54 to 59.44 3.07% 1.88 times
10 Fri Jul 2026 57.57 56.94 to 58.08 -0.64% 0.71 times
09 Thu Jul 2026 57.94 57.14 to 58.00 0.71% 0.76 times
08 Wed Jul 2026 57.53 57.34 to 58.23 -0.78% 0.61 times
07 Tue Jul 2026 57.98 56.70 to 58.49 2.26% 0.95 times
06 Mon Jul 2026 56.70 56.49 to 58.11 -2.43% 1.45 times
02 Thu Jul 2026 58.11 56.05 to 58.14 2.92% 0.68 times
01 Wed Jul 2026 56.46 56.30 to 57.90 -2% 0.9 times

Videos related to: BMY announcements Bristol-myers Squibb Company announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

BMY announcements Bristol-myers Squibb Company announcements and dividends declared NYSE

 

Back to top